Clinical Trials Browser

Phase 1/2 × Hypereosinophilic Syndrome × nilotinib × Clear all

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome, Mastocytosis, Systemic, Precursor Cell Lymphoblastic Leukemia-Lymphoma